Stratégies de prise en charge des métastases cérébrales des malades atteints de cancers bronchiques primitifs

Fabrice Barlesi; Natalia Khobta; Agnès Tallet; Anthony Goncalves; David Azria; Jean Philippe Spano; Antoine F. Carpentier; Jean Régis; Philippe Metellus

doi:10.1684/bdc.2013.1721

Stratégies de prise en charge des métastases cérébrales des malades atteints de cancers bronchiques primitifs

Fabrice Barlesi, Natalia Khobta, Agnès Tallet, Anthony Goncalves, David Azria, Jean Philippe Spano, Antoine F. Carpentier, Jean Régis, Philippe Metellus

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

10 Citations (Scopus)

Résumé

Brain metastases from primary lung cancer represent 40% of all brain metastases. On the other hand, 10 to 80% of primary lung cancer patients will present with synchronous or metachronous brain metastases. Management of these patients is therefore a big challenge. The management will depend on the circumstances of diagnosis (symptomatic or not), the cancer history (synchronous or metachronous brain metastases), the histology and the number of lesions.

Titre traduit de la contribution	[Management of brain metastases for lung cancer patients].
langue originale	Français
Pages (de - à)	303-308
Nombre de pages	6
journal	Unknown Journal
Volume	100
Numéro de publication	3
Les DOIs	https://doi.org/10.1684/bdc.2013.1721
état	Publié - 1 janv. 2013
Modification externe	Oui

Accès au document

10.1684/bdc.2013.1721

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{90949d8f49074e1fab421734f037efcd,

title = "Strat{\'e}gies de prise en charge des m{\'e}tastases c{\'e}r{\'e}brales des malades atteints de cancers bronchiques primitifs",

abstract = "Brain metastases from primary lung cancer represent 40% of all brain metastases. On the other hand, 10 to 80% of primary lung cancer patients will present with synchronous or metachronous brain metastases. Management of these patients is therefore a big challenge. The management will depend on the circumstances of diagnosis (symptomatic or not), the cancer history (synchronous or metachronous brain metastases), the histology and the number of lesions.",

author = "Fabrice Barlesi and Natalia Khobta and Agn{\`e}s Tallet and Anthony Goncalves and David Azria and Spano, {Jean Philippe} and Carpentier, {Antoine F.} and Jean R{\'e}gis and Philippe Metellus",

year = "2013",

month = jan,

day = "1",

doi = "10.1684/bdc.2013.1721",

language = "Fran{\c c}ais",

volume = "100",

pages = "303--308",

journal = "Unknown Journal",

number = "3",

}

TY - JOUR

T1 - Stratégies de prise en charge des métastases cérébrales des malades atteints de cancers bronchiques primitifs

AU - Barlesi, Fabrice

AU - Khobta, Natalia

AU - Tallet, Agnès

AU - Goncalves, Anthony

AU - Azria, David

AU - Spano, Jean Philippe

AU - Carpentier, Antoine F.

AU - Régis, Jean

AU - Metellus, Philippe

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Brain metastases from primary lung cancer represent 40% of all brain metastases. On the other hand, 10 to 80% of primary lung cancer patients will present with synchronous or metachronous brain metastases. Management of these patients is therefore a big challenge. The management will depend on the circumstances of diagnosis (symptomatic or not), the cancer history (synchronous or metachronous brain metastases), the histology and the number of lesions.

AB - Brain metastases from primary lung cancer represent 40% of all brain metastases. On the other hand, 10 to 80% of primary lung cancer patients will present with synchronous or metachronous brain metastases. Management of these patients is therefore a big challenge. The management will depend on the circumstances of diagnosis (symptomatic or not), the cancer history (synchronous or metachronous brain metastases), the histology and the number of lesions.

UR - http://www.scopus.com/inward/record.url?scp=84877929382&partnerID=8YFLogxK

U2 - 10.1684/bdc.2013.1721

DO - 10.1684/bdc.2013.1721

M3 - Article

C2 - 23518334

AN - SCOPUS:84877929382

VL - 100

SP - 303

EP - 308

JO - Unknown Journal

JF - Unknown Journal

IS - 3

ER -